Quartz·2 min read·hard
FDA panel overrules its own scientists to ease access to unproven peptide injections
✦AI Summary
An FDA advisory committee has voted to recommend allowing compounding pharmacies to provide access to several unproven peptide injections, including BPC-157 and TB-500. This decision comes despite opposition from the FDA's own scientists regarding the safety and efficacy of these substances.
The Pharmacy Compounding Advisory Committee voted 8-6 to recommend BPC-157, KPV, TB-500, and MOTS-c for compounding pharmacy access
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in